Literature DB >> 33422078

Impact of placental malaria on maternal, placental and fetal cord responses and its role in pregnancy outcomes in women from Blue Nile State, Sudan.

Samia Omer1, Clara Franco-Jarava2, Ali Noureldien3, Mona Omer4, Mutasim Abdelrahim5, Israel Molina6, Ishag Adam7.   

Abstract

BACKGROUND: The sequestration of Plasmodium falciparum infected cells in the placenta results in placental malaria (PM). It activates the mother's immune cells and induces secretion of inflammatory cytokines, which might influence pregnancy outcomes. This study aims to investigate the cytokines (levels IL-4, IL-6, IL-10, IL-17A, and INF γ) in maternal peripheral, placental, and umbilical cord blood in response to PM and the extent to which this may influence maternal haemoglobin levels and birth weight.
METHODS: A total of 185 consenting Sudanese women from Blue Nile State were enrolled at delivery time in a cross-sectional study conducted between Jan 2012-Dec 2015. Malaria infection in the collected maternal peripheral, placental, umbilical cord samples was determined microscopically, and ELISA was used to measure the plasma levels IL-4, IL-6, IL-10, IL-17A, and INF γ in the collected positive and negative malaria samples.
RESULTS: Elevated levels of IL-4 and IL-10 and reduced levels of IL-6 were detected in the malaria positive samples in comparison to the negative ones in the three types of the samples investigated. Maternal, IL-4 and IL-10 were significantly higher in the samples collected from the PM infected group compared to the non-infected control (P < 0.001). While the absence of PM was significantly associated with the IL-6 and maternal IFN-γ levels, maternal IL-17A, placental and umbilical cord IFN-γ levels showed no significant difference (P = 0.214, P = 0.065, P = 0.536, respectively) due to infection. Haemoglobin level and birth weight were increased in the group with high levels of IL-6 and IL-17A, but not in the group with IL-4 and IL-10 levels. While significantly negative correlation was found between IFN-γ levels and birth weight for all three types of samples, only maternal peripheral IFN-γ level was significantly positively correlated with maternal haemoglobin (r = 0.171, P = 0.020).
CONCLUSION: These results suggest that PM induces mother's immune response and impairs her cytokine profile, which might alter maternal haemoglobin levels and the baby's birth weight.

Entities:  

Keywords:  Birth weight; Blue Nile State Sudan; Cytokines; Placental malaria

Mesh:

Year:  2021        PMID: 33422078      PMCID: PMC7797158          DOI: 10.1186/s12936-021-03580-x

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  42 in total

Review 1.  Malaria in pregnancy: pathogenesis and immunity.

Authors:  Stephen J Rogerson; Lars Hviid; Patrick E Duffy; Rose F G Leke; Diane W Taylor
Journal:  Lancet Infect Dis       Date:  2007-02       Impact factor: 25.071

Review 2.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

Review 3.  Th1-type immunity is incompatible with successful pregnancy.

Authors:  R Raghupathy
Journal:  Immunol Today       Date:  1997-10

4.  Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria.

Authors:  J M Moore; B L Nahlen; A Misore; A A Lal; V Udhayakumar
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

5.  Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes.

Authors:  Stephen J Rogerson; Elena Pollina; Abera Getachew; Eyob Tadesse; Valentino M Lema; Malcolm E Molyneux
Journal:  Am J Trop Med Hyg       Date:  2003-01       Impact factor: 2.345

6.  Elevated gamma interferon-producing NK cells, CD45RO memory-like T cells, and CD4 T cells are associated with protection against malaria infection in pregnancy.

Authors:  Caroline Othoro; Julie M Moore; Kathleen A Wannemuehler; Sichangi Moses; Altaf Lal; Juliana Otieno; Bernard Nahlen; Laurence Slutsker; Ya Ping Shi
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

7.  Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.

Authors:  Ali Salanti; Madeleine Dahlbäck; Louise Turner; Morten A Nielsen; Lea Barfod; Pamela Magistrado; Anja T R Jensen; Thomas Lavstsen; Michael F Ofori; Kevin Marsh; Lars Hviid; Thor G Theander
Journal:  J Exp Med       Date:  2004-11-01       Impact factor: 14.307

8.  Placental malaria and its effect on pregnancy outcomes in Sudanese women from Blue Nile State.

Authors:  Samia A Omer; Hagir E Idress; Ishag Adam; Mutasim Abdelrahim; Ali N Noureldein; Abdelrahim M Abdelrazig; Mohammed O Elhassan; Suad M Sulaiman
Journal:  Malar J       Date:  2017-09-16       Impact factor: 2.979

9.  Plasmodium falciparum infection dysregulates placental autophagy.

Authors:  Flávia Afonso Lima; André Barateiro; Jamille Gregório Dombrowski; Rodrigo Medeiros de Souza; Douglas de Sousa Costa; Oscar Murillo; Sabrina Epiphanio; Lígia Antunes Gonçalves; Claudio Romero Farias Marinho
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

10.  Cytokine response to pregnancy-associated recrudescence of Plasmodium berghei infection in mice with pre-existing immunity to malaria.

Authors:  Rosette Megnekou; Trine Staalsoe; Lars Hviid
Journal:  Malar J       Date:  2013-11-01       Impact factor: 2.979

View more
  2 in total

1.  Frequency of placental malaria and its associated factors in northwestern Colombia, pooled analysis 2009-2020.

Authors:  Jaiberth Antonio Cardona-Arias; Jaime Carmona-Fonseca
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

2.  Congenital malaria: Frequency and epidemiology in Colombia, 2009-2020.

Authors:  Jaiberth Antonio Cardona-Arias; Jaime Carmona-Fonseca
Journal:  PLoS One       Date:  2022-02-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.